Optimizing the Conditioning Regimen for HCT in Myelofibrosis: Long-term Results of a Prospective Phase II Clinical Trial

BACKGROUND: Optimal conditioning regimen for older patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (HCT) is not known. Likewise, role of dose intensity is not clear. METHODS: We conducted a non-randomized prospective phase II trial using low-dose, later escalated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Popat, Uday, Mehta, Rohtesh S., Bassett, Roland, Kongtim, Piyanuch, Chen, Julianne, Alousi, Amin M., Anderlini, Paolo, Ciurea, Stefan, Hosing, Chitra, Jones, Roy, Kebriaei, Partow, Khouri, Issa, Lindsay, Richard, Nieto, Yago, Olson, Amanda, Oran, Betul, Qazilbash, Muzaffar H., Rondon, Gabriela, Shpall, Elizabeth J., Verstovsek, Srdan, Andersson, Borje S., Champlin, Richard E.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547798/
https://ncbi.nlm.nih.gov/pubmed/32438043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.03.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars